The global pharmacovigilance
Posted: Wed Feb 05, 2025 10:45 am
Cclinical trial phase, market is segmented into preclinical, phase I, phase II, phase III, and phase IV
By service provider, the global market is classified into in-house, contract, and outsourcing
By type of reporting, the target market is bifurcated france rcs data into spontaneous reporting, intensified ADR reporting, targeted spontaneous reporting, cohort event monitoring, and EHR mining
By end-user, the target market is segmented into hospitals, pharmaceutical companies, and others
By region, The North America region is expected to dominate the global market over the forecast period due to the concentration of the drug manufacturing companies.
The pharmaceutical companies in the North America region is investing heavily in drug development, the usage of the pharmacovigilance is more in this region. The Asia Pacific is expected to show significant growth during the forecast period because of the rise in several vendors providing cost-effective pharmacovigilance services.
By service provider, the global market is classified into in-house, contract, and outsourcing
By type of reporting, the target market is bifurcated france rcs data into spontaneous reporting, intensified ADR reporting, targeted spontaneous reporting, cohort event monitoring, and EHR mining
By end-user, the target market is segmented into hospitals, pharmaceutical companies, and others
By region, The North America region is expected to dominate the global market over the forecast period due to the concentration of the drug manufacturing companies.
The pharmaceutical companies in the North America region is investing heavily in drug development, the usage of the pharmacovigilance is more in this region. The Asia Pacific is expected to show significant growth during the forecast period because of the rise in several vendors providing cost-effective pharmacovigilance services.